Skip to main content
. 2022 Apr 14;35:10048. doi: 10.3389/ti.2022.10048

TABLE 3.

post-LuTX outcomes.

TLVRS (n = 26) CLVRS (n = 328) p = TELVR (n = 56) CELVR (n = 270) p =
Surgical revision 5 (19.2%) 17.7% 0.843 8 (14.3%) 16.2% 0.708
Successful weaning 24 (96.0%) 95.5% 0.894 55 (98.2%) 98.3% 0.973
Days ventilated 2 (0.5–23) 2 (0.5–79) 0.159 2 (0.5–19) 2 (0.5–79) 0.563
Post-OP ECMO 4 (15.4%) 3.8% 0.006 1 (1.8%) 6.4% 0.179
Post-OP ECMO (days) 7 (3–9) 4 (2–10) 0.078 2 (2–2) 5 (2–10) 0.250
Days on ICU 7 (3–213) 6 (2–152) 0.149 6 (2–107) 7 (2–152) 0.127
Days to transfer to normal ward 11 (5–213) 10 (3–118) 0.154 9 (2–107) 9 (2–118) 0.382
Days to dismissal from hospital 35 (15–105) 37 (9–152) 0.717 42 (18–109) 35 (8–152) 0.158
Death before dismissal 2 (7.7%) 8.0% 0.963 1 (1.8%) 5.8% 0.203

Control columns consist of weighted data; TLVRS, patients with previous LVRS; CLVRS, matched controls; TELVR, patients with previous ELVR; CELVR, matched controls; surgical revisions include all later surgical interventions on the chest and the lungs; ICU, intensive care unit. Significant p values are highlited in bold italic.